
Oncology NEWS International
- Oncology NEWS International Vol 16 No 5
- Volume 16
- Issue 5
Charlie Rose Program Highlights Ca Research
Martin D. Abeloff, MD, Editor-in-Chief of Oncology News International, was a recent featured guest on "The Charlie Rose Science Series" on PBS television. The episode, entitled "The Latest in Cancer Research," was the fourth in a 12-part special series focusing on the importance of scientific research in human health.
NEW YORKMartin D. Abeloff, MD, Editor-in-Chief of Oncology News International, was a recent featured guest on "The Charlie Rose Science Series" on PBS television. The episode, entitled "The Latest in Cancer Research," was the fourth in a 12-part special series focusing on the importance of scientific research in human health.
Dr. Abeloff, professor and director, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, was one of a panel of four oncology thought leaders who highlighted milestones in cancer genetics and research. Other panelists included Harold Varmus, MD, president, Memorial Sloan-Kettering Cancer Center; David G. Nathan, MD, president emeritus, Dana-Farber Cancer Institute; and Deborah Schrag, MD, associate attending physician, Memorial Sloan-Kettering Cancer Center.
The Science Series is underwritten by Pfizer, Inc. Episodes 1, 2, and 3 focused on the brain, the human genome, and longevity, respectively. Sir Paul M. Nurse, PhD, president of The Rockefeller University and the 2001 Nobel Prize Laureate in Physiology or Medicine, is Mr. Rose's co-host for the series.
Video clips from past episodes in the series are posted to
Articles in this issue
almost 19 years ago
Escalating Drug Costs Could Provoke Consumer Backlashalmost 19 years ago
Large Study Casts Doubt on Value of CADalmost 19 years ago
Cetuximab Does Not Increase Mucositis in H&N Canceralmost 19 years ago
2004 Update Shows Continued Lower Breast Ca Incidencealmost 19 years ago
Reclast Single-Dose Infusion Approved for Paget's Diseasealmost 19 years ago
Fragmin Approved for VTE in Cancer Ptsalmost 19 years ago
New Phase III Trial of Genasense in Advanced Melanoma Plannedalmost 19 years ago
Cervical Cancer Vaccines Show Sustained Protectionalmost 19 years ago
The 'New' Medicare: Passive Payer No More; PQRI Is First StepNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.



































